This inflammasome was later shown to drive HCC in the DEN mouse model, where Aim2−/− or Casp1−/− mice had reduced carcinogenic liver injury and cancer growth (Martínez-Cardona et al., 2018). This evidence concerns the gene CASP1 and cancer.